Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity

被引:42
作者
Ungaro, Francesca [1 ]
Conte, Claudia [1 ]
Ostacolo, Luisanna [1 ]
Maglio, Giovanni [2 ]
Barbieri, Antonio [3 ]
Arra, Claudio [3 ]
Misso, Gabriella [4 ]
Abbruzzese, Alberto [4 ]
Caraglia, Michele [4 ]
Quaglia, Fabiana [1 ]
机构
[1] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Chem Paolo Corradini, I-80131 Naples, Italy
[3] Natl Canc Inst Fdn G, Ist Nazl Tumori, Dept Res, Expt Pharmacol Unit, Naples, Italy
[4] Univ Naples Federico II, Sch Med, Dept Biochem & Biophys, Naples, Italy
关键词
Nanoparticles; Amphiphilic block copolymers; Anticancer drugs; Docetaxel; PLGA NANOPARTICLES; MICELLES; BIODISTRIBUTION; CHEMOTHERAPY; CANCER; PHARMACOKINETICS; PACLITAXEL; DELIVERY; DESIGN;
D O I
10.1016/j.nano.2011.08.012
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Amphiphilic block copolymers of poly(epsilon-caprolactone) and poly(ethylene oxide) were assembled in core-shell nanoparticles (NPs) by a melting-sonication technique (MeSo). The entrapment of the poorly water-soluble anticancer drug docetaxel (DTX), nanocarrier cytotoxicity toward different cells and toxicity in mice were investigated. The encapsulation mechanism was rationalized and related to copolymer properties such as crystallinity and drug solubility in the copolymer phase. DTX release from NPs occurred in 2 drug pulses over 30 days. DTX entrapment in NPs strongly decreased haemolysis of erythrocytes in comparison with a commercial DTX formulation. In comparison with free DTX, NPs were both more efficient in inhibiting cell growth of breast and prostate cancer cells and less toxic in experimental animal models. The results of this study indicate that MeSo is an interesting technique for the achievement of peculiar core-shell nanocarriers for the passive targeting and sustained release of poorly water-soluble anticancer drugs.
引用
收藏
页码:637 / 646
页数:10
相关论文
共 33 条
  • [1] Factors affecting the clearance and biodistribution of polymeric nanoparticles
    Alexis, Frank
    Pridgen, Eric
    Molnar, Linda K.
    Farokhzad, Omid C.
    [J]. MOLECULAR PHARMACEUTICS, 2008, 5 (04) : 505 - 515
  • [2] Micelles of methoxy poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization and controlled delivery of Cyclosporine A
    Aliabadi, HM
    Mahmud, A
    Sharifabadi, AD
    Lavasanifar, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 104 (02) : 301 - 311
  • [3] Nano-engineering block copolymer aggregates for drug delivery
    Allen, C
    Maysinger, D
    Eisenberg, A
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) : 3 - 27
  • [4] Anton N, 2008, J CONTROL RELEASE, V128, P185, DOI 10.1016/j.jconrel.2008.02.007
  • [5] The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-α and EGF in human cancer cells
    Caraglia, M
    Marra, M
    Giuberti, G
    D'Alessandro, AM
    Baldi, A
    Tassone, P
    Venuta, S
    Tagliaferri, P
    Abbruzzese, A
    [J]. JOURNAL OF BIOCHEMISTRY, 2003, 133 (06) : 757 - 765
  • [6] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741
    Citron, ML
    Berry, DA
    Cirrincione, C
    Hudis, C
    Winer, EP
    Gradishar, WJ
    Davidson, NE
    Martino, S
    Livingston, R
    Ingle, JN
    Perez, EA
    Carpenter, J
    Hurd, D
    Holland, JF
    Smith, BL
    Sartor, CI
    Leung, EH
    Abrams, J
    Schilsky, RL
    Muss, HB
    Norton, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) : 1431 - 1439
  • [7] Nanotechnology: Intelligent design to treat complex disease
    Couvreur, Patrick
    Vauthier, Christine
    [J]. PHARMACEUTICAL RESEARCH, 2006, 23 (07) : 1417 - 1450
  • [8] Nanoparticle therapeutics: an emerging treatment modality for cancer
    Davis, Mark E.
    Chen, Zhuo
    Shin, Dong M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) : 771 - 782
  • [9] Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer
    De Souza, Raquel
    Zahedi, Payam
    Moriyama, Eduardo H.
    Allen, Christine J.
    Wilson, Brian C.
    Piquette-Miller, Micheline
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1820 - 1830
  • [10] PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution
    Esmaeili, Farnaz
    Ghahremani, Mohammad Hossein
    Esmaeili, Behnaz
    Khoshayand, Mohammad Reza
    Atyabi, Fatemeh
    Dinarvand, Rassoul
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 349 (1-2) : 249 - 255